Man Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.9M | Buy |
90,235
+75,805
| +525% | +$21M | 0.03% | 510 |
|
|
2026
Q1 | $4.26M | Sell |
14,430
-39,274
| -73% | -$11.7M | 0.01% | 1234 |
|
|
2025
Q4 | $14.7M | Sell |
53,704
-1,148
| -2% | -$312K | 0.02% | 639 |
|
|
2025
Q3 | $14.8M | Sell |
54,852
-168,434
| -75% | -$45.8M | 0.03% | 617 |
|
|
2025
Q2 | $61.5M | Buy |
223,286
+72,370
| +48% | +$19.7M | 0.12% | 194 |
|
|
2025
Q1 | $40M | Sell |
150,916
-41,104
| -21% | -$10.1M | 0.1% | 237 |
|
|
2024
Q4 | $44.6M | Buy |
192,020
+22,049
| +13% | +$5.07M | 0.12% | 209 |
|
|
2024
Q3 | $37.5M | Sell |
169,971
-67,397
| -28% | -$13.9M | 0.1% | 260 |
|
|
2024
Q2 | $46.7M | Buy |
237,368
+49,464
| +26% | +$10.2M | 0.12% | 192 |
|
|
2024
Q1 | $40.5M | Buy |
187,904
+48,623
| +35% | +$10.2M | 0.1% | 220 |
|
|
2023
Q4 | $29.3M | Buy |
+139,281
| New | +$29.7M | 0.08% | 282 |
|
|
2023
Q3 | – | Sell |
-45,089
| Closed | -$8.96M | – | 502 |
|
|
2023
Q2 | $8.35M | Buy |
+45,089
| New | +$8.33M | 0.03% | 684 |
|
|
2023
Q1 | – | Sell |
-88,169
| Closed | -$15.9M | – | 825 |
|
|
2022
Q4 | $14.8M | Buy |
88,169
+7,482
| +9% | +$1.3M | 0.05% | 421 |
|
|
2022
Q3 | $14.3M | Buy |
+80,687
| New | +$15.9M | 0.07% | 355 |
|
|
2022
Q2 | – | Sell |
-154,345
| Closed | -$32.7M | – | 140 |
|
|
2022
Q1 | $36.7M | Buy |
154,345
+23,560
| +18% | +$5.53M | 0.13% | 174 |
|
|
2021
Q4 | $29.9M | Buy |
130,785
+11,682
| +10% | +$2.57M | 0.1% | 240 |
|
|
2021
Q3 | $23M | Buy |
119,103
+35,584
| +43% | +$7.21M | 0.08% | 288 |
|
|
2021
Q2 | $17.8M | Buy |
83,519
+34,044
| +69% | +$7.19M | 0.06% | 350 |
|
|
2021
Q1 | $10.1M | Sell |
49,475
-25,112
| -34% | -$4.95M | 0.04% | 428 |
|
|
2020
Q4 | $13.6M | Sell |
74,587
-40,939
| -35% | -$6.96M | 0.06% | 334 |
|
|
2020
Q3 | $19.3M | Buy |
115,526
+22,597
| +24% | +$3.81M | 0.08% | 285 |
|
|
2020
Q2 | $15.1M | Buy |
92,929
+38,361
| +70% | +$6.88M | 0.08% | 244 |
|
|
2020
Q1 | $9.44M | Sell |
54,568
-106,474
| -66% | -$21.2M | 0.06% | 307 |
|
|
2019
Q4 | $32.3M | Buy |
161,042
+1,858
| +1% | +$381K | 0.11% | 225 |
|
|
2019
Q3 | $33.6M | Sell |
159,184
-22,075
| -12% | -$4.61M | 0.13% | 196 |
|
|
2019
Q2 | $35.2M | Buy |
181,259
+26,334
| +17% | +$4.85M | 0.13% | 191 |
|
|
2019
Q1 | $25.5M | Buy |
154,925
+23,440
| +18% | +$4.14M | 0.1% | 255 |
|
|
2018
Q4 | $24.7M | Sell |
131,485
-233
| -0.2% | -$43K | 0.11% | 198 |
|
|
2018
Q3 | $22.4M | Sell |
131,718
-28,847
| -18% | -$4.86M | 0.08% | 280 |
|
|
2018
Q2 | $26.3M | Buy |
160,565
+47,707
| +42% | +$7.79M | 0.11% | 192 |
|
|
2018
Q1 | $18.3M | Buy |
+112,858
| New | +$18M | 0.08% | 260 |
|
Other funds holding CME
Man Group's CME Position: Q2 2026 in Review
Man Group increased its CME Group (CME) stake by 525% in Q2 2026, buying an estimated $21M and bringing the position to 90,235 shares worth $19.9M. The position accounts for 0.03% of the portfolio, ranked #510.
Man Group first reported a position in CME in Q1 2018 and has held it in 31 quarters since. The position peaked at $61.5M in Q2 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Man Group held 90,235 shares of CME Group worth $19.9M as of Q2 2026.
- Man Group bought 75,805 CME Group shares in Q2 2026, an estimated $21M.
- CME Group made up 0.03% of Man Group's portfolio in Q2 2026, its #510 holding.
- Man Group first reported a position in CME Group in Q1 2018 and has held it in 31 quarters since.
- Man Group's CME Group position peaked at $61.5M in Q2 2025.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.